Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Humphreys

Showing results (61-70 of 449) with videos related to

Pageof 45
Sort By:
Drug and Alcohol Review|November 26, 2013
Recovery-oriented policy and care systems in the UK and USAKeith Humphreys, Anna Lembke
Statistical Methods in Medical Research|November 7, 2017
Modelling breast cancer tumour growth for a stable disease populationGabriel Isheden, Keith Humphreys
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|March 15, 2018
The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction MedicineAnna Lembke, Keith Humphreys
Addiction (Abingdon, England)|February 15, 2007
The psychological science of addictionElizabeth Gifford, Keith Humphreys
Statistical Methods in Medical Research|February 1, 2022
Estimating latent, dynamic processes of breast cancer tumour growth and distant metastatic spread from mammography screening dataAlessandro Gasparini, Keith Humphreys
Mathematical Biosciences|October 19, 2019
Statistical models of tumour onset and growth for modern breast cancer screening cohortsJ Rickard Strandberg, Keith Humphreys
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Recreational cannabis legalization presents an opportunity to reduce the harms of the US medical cannabis industryKeith Humphreys, Chelsea L Shover
Drug and Alcohol Dependence|October 9, 2019
Predictors of availability of long-acting medication for opioid use disorderChelsea L Shover, Keith Humphreys
The American Journal of Drug and Alcohol Abuse|March 15, 2019
Six policy lessons relevant to cannabis legalizationChelsea L Shover, Keith Humphreys
Cureus|July 24, 2020
Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?Chelsea L Shover, Keith Humphreys
Pageof 45

Showing results (61-70 of 449) with videos related to

Sort By:
Pageof 45
Drug and Alcohol Review|November 26, 2013
Recovery-oriented policy and care systems in the UK and USAKeith Humphreys, Anna Lembke
Statistical Methods in Medical Research|November 7, 2017
Modelling breast cancer tumour growth for a stable disease populationGabriel Isheden, Keith Humphreys
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|March 15, 2018
The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction MedicineAnna Lembke, Keith Humphreys
Addiction (Abingdon, England)|February 15, 2007
The psychological science of addictionElizabeth Gifford, Keith Humphreys
Statistical Methods in Medical Research|February 1, 2022
Estimating latent, dynamic processes of breast cancer tumour growth and distant metastatic spread from mammography screening dataAlessandro Gasparini, Keith Humphreys
Mathematical Biosciences|October 19, 2019
Statistical models of tumour onset and growth for modern breast cancer screening cohortsJ Rickard Strandberg, Keith Humphreys
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Recreational cannabis legalization presents an opportunity to reduce the harms of the US medical cannabis industryKeith Humphreys, Chelsea L Shover
Drug and Alcohol Dependence|October 9, 2019
Predictors of availability of long-acting medication for opioid use disorderChelsea L Shover, Keith Humphreys
The American Journal of Drug and Alcohol Abuse|March 15, 2019
Six policy lessons relevant to cannabis legalizationChelsea L Shover, Keith Humphreys
Cureus|July 24, 2020
Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?Chelsea L Shover, Keith Humphreys
Pageof 45